Andrew Pipe, MD
Ottawa Heart Institute Research Corporation · The University of Ottawa Heart Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrew Pipe, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:40 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05157932 · An Evaluation of the Talk Test for Exercise Prescription for Home-Based Cardiac RehabilitationOttawa Heart Institute Research Corporation · active not recruiting · Coronary Artery Disease · study chair
- N/ANCT04286295 · Cytisine Compared to Combination NRT in Relapsed SmokersOttawa Heart Institute Research Corporation · terminated · Smoking Cessation, Coronary Artery Disease · principal investigator
- Ph4NCT02918500 · Effect of Pre-op NRT on Peri-operative Complications and Long-term Abstinence: A Pilot Trial in Patients Undergoing CABG SurgeryOttawa Heart Institute Research Corporation · terminated · Smoking Cessation · principal investigator
- N/ANCT01980017 · Evaluation of the Ottawa Model for Smoking Cessation in Diabetes Education ProgramsOttawa Heart Institute Research Corporation · completed · Pre-diabetic, Diabetic Type II Mellitus · study chair
- N/ANCT01658683 · The Efficacy and Economics of Exercise Maintenance Post-Cardiac RehabilitationOttawa Heart Institute Research Corporation · completed · Coronary Artery Disease · study chair
- Ph4NCT01623505 · Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural CounselingOttawa Heart Institute Research Corporation · completed · Smoking Cessation, Psychiatric Illness · study chair
- N/ANCT01603524 · Integrating the "Ottawa Model" for Smoking Cessation Into Primary Care PracticeOttawa Heart Institute Research Corporation · completed · Smoking Cessation · principal investigator
- Ph4NCT00962988 · Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular DiseaseOttawa Heart Institute Research Corporation · completed · Cerebrovascular Disorders, Smoking Cessation · study chair
- Ph4NCT00959972 · Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart DiseaseOttawa Heart Institute Research Corporation · completed · Coronary Heart Disease · study chair
- Ph1NCT00250913 · The Efficacy and Cost-Effectiveness of Behavioral Counseling for Exercise in Men and Women Following Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI)Ottawa Heart Institute Research Corporation · completed · Coronary Arteriosclerosis, Myocardial Infarction · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.